These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 10212830

  • 21. Insulin mediators in man: effects of glucose ingestion and insulin resistance.
    Shashkin PN, Shashkina EF, Fernqvist-Forbes E, Zhou YP, Grill V, Katz A.
    Diabetologia; 1997 May; 40(5):557-63. PubMed ID: 9165224
    [Abstract] [Full Text] [Related]

  • 22. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
    Croze ML, Soulage CO.
    Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
    [Abstract] [Full Text] [Related]

  • 23. Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients.
    Genazzani AD, Prati A, Santagni S, Ricchieri F, Chierchia E, Rattighieri E, Campedelli A, Simoncini T, Artini PG.
    Gynecol Endocrinol; 2012 Dec; 28(12):969-73. PubMed ID: 22612517
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
    Márquez L, González N, Puente J, Valverde L, Villanueva-Peñacarrillo ML.
    Diabetes Nutr Metab; 2001 Oct; 14(5):239-44. PubMed ID: 11806463
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Urinary chiro-inositol and myo-inositol excretion is elevated in the diabetic db/db mouse and streptozotocin diabetic rat.
    Kawa JM, Przybylski R, Taylor CG.
    Exp Biol Med (Maywood); 2003 Sep; 228(8):907-14. PubMed ID: 12968062
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Circulating factors and insulin resistance. II. The action of the novel myo-inositol cyclic 1,2-inositol phosphate phosphoglycan insulin antagonist from human plasma in regulating pyruvate dehydrogenase phosphatase.
    Galasko GT, Abe S, Lilley K, Zhang C, Larner J.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1051-7. PubMed ID: 8772575
    [Abstract] [Full Text] [Related]

  • 36. D-chiro-inositol metabolism in diabetes mellitus.
    Ostlund RE, McGill JB, Herskowitz I, Kipnis DM, Santiago JV, Sherman WR.
    Proc Natl Acad Sci U S A; 1993 Nov 01; 90(21):9988-92. PubMed ID: 8234346
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Synthetic inositol phosphoglycans related to GPI lack insulin-mimetic activity.
    Hecht ML, Tsai YH, Liu X, Wolfrum C, Seeberger PH.
    ACS Chem Biol; 2010 Nov 19; 5(11):1075-86. PubMed ID: 20825209
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.